Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Claudia Stanciu-Pop"'
Autor:
Cédric Mahiat, Benoît Bihin, Fabrice Duplaquet, Claudia Stanciu Pop, Michael Dupont, Thierry Vander Borght, Benoît Rondelet, Jean Vanderick, Bénédicte André, Lionel Pirard, Sebahat Ocak
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 4, p 3618 (2023)
Biomarkers of systemic inflammation/nutritional status have been associated with outcomes in advanced-stage non-small-cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICIs). However, most of them were not tested in cohorts of patie
Externí odkaz:
https://doaj.org/article/07ee61c9fc7e46f694f7e91714afaceb
Autor:
Nunzia Di Maggio, Claudia Stanciu Pop, Anna Marsano, Ludovic Melly, Benoît Rondelet, Chu Yu-Hsuan, Christian Schachtrup, Marie-Cécile Nollevaux, Andrea Banfi, Andrea Grosso
Publikováno v:
Journal of tissue engineering and regenerative medicine, Vol. 14, no. 10, p. 1513-1523 (2020)
Therapeutic angiogenesis is the delivery of factors to promote vascular growth and holds promise for the treatment of ischemic heart conditions. Recombinant protein delivery to the myocardium by factor-decorated fibrin matrices is an attractive appro
Autor:
Etienne El-Helou, Claudia Stanciu-Pop, Michel Moreau, Marie Chintinne, Nicolas Sirtaine, Denis Larsimont, Isabelle Veys, Catalin Florin Pop
Publikováno v:
Mastology.
Objective: Nearly 1/5 of women with breast cancer (BC) treated by breast-conserving surgery (BCS) require reoperation due to positive margins on final pathology. In our hospital practice, intraoperative macroscopic pathological margin evaluation (IMP
Autor:
Claudia Stanciu-Pop, Etienne El Helou, Eddy Eddy, Michel Moreau, Simona Picchia, Marie Chintinne, Nicolas Sirtaine, Denis Larsimont, Isabelle Veys, Catalin Florin Pop
Publikováno v:
European Journal of Surgical Oncology. 49:e106
Autor:
Camille Verocq, Myriam Remmelink, Sarah De Clercq, Isabelle Salmon, Laureen Rocq, Christophe Compère, Sebahat Ocak, Audrey Verrellen, Nicky D'Haene, Christine Decaestecker, Claudia Stanciu‑Pop, Zita Mekinda
Publikováno v:
Oncology letters, Vol. 19, no. 5, p. 3400-3410 (2020)
Oncology Letters, 19 (5
Oncology Letters
Oncology Letters, 19 (5
Oncology Letters
Treatment with pembrolizumab, an anti-programmed cell death-1 (PDCD-1) monoclonal antibody for the treatment of non-small cell lung cancers (NSCLCs) requires prior immunohistochemical (IHC) analysis of the expression of the programmed death-ligand 1
Autor:
Claudia Stanciu-Pop, Stylianos Drisis, Denis Larsimont, Magali Radermeker, Carine Vandemerckt, D. Noterman, Jean-Marie Nogaret, C.F. Pop, Michel Moreau, Isabelle Veys
Publikováno v:
The Breast Journal. 24:927-933
Background The size and focality of the primary tumor in breast cancer (BC) influence therapeutic decision making. The purpose of this study was to evaluate whether preoperative breast magnetic resonance imaging (MRI) is helpful for the assessment of